Medtech firm Zimmer Biomet Holdings beat Wall Street estimates for first-quarter profit on Thursday, on the back of robust demand for its devices that are used in knee and hip reconstruction procedures. Zimmer's results extend a strong quarter for medical device makers, including peer Stryker Corp which raised its annual profit outlook betting on steady demand for its hip and knee implants. Investors have increased expectations for medical device makers following a post-pandemic surge in demand for medical procedures, especially among older Americans.
States, UTs, private hospitals seek more time for consultations on standard rates post Supreme Court directive. Court to hear plea by doctors, hospitals on government s rate prescription. Concerns raised on revenue impact. The order has led to widespread panic among private hospitals and investors, since standardisation of rates could substantially affect the revenue and commercial viability of hospital operations. Subsequently, healthcare providers wrote to the health ministry and the court, raising their concerns.
Nine couples are suing an Orange County IVF clinic after they claim the clinic killed their embryos and tried to cover up the mistake. According to the couples’ lawyers at Marcereau Law Group and Ikuta Hemesath LLP, Ovation Fertility made mistakes at its Newport Beach laboratory, then “knowingly implanted dead embryos into would-be mothers and […]
Fintech lender Affirm has started quietly offering "buy now, pay later" (BNPL) loans for elective medical procedures, in a major push beyond its core e-commerce market, the company told Reuters. Over the past year, Affirm has more than doubled the number of elective medical merchants on its network, reaching around 130 at of the end of 2023. The San Francisco-based company is hoping to tap growing consumer demand for financing for cosmetic treatments, dental services, medical devices and veterinary procedures.